# Title
Human B-Species
immunodeficiency I-Species
virus I-Species
type I-Species
1 I-Species
Tat B-Gene
protein O
decreases O
cyclic B-Chemical
AMP I-Chemical
synthesis O
in O
rat B-Species
microglia O
cultures. O

# Abstract
We O
have O
studied O
the O
modulation O
of O
cyclic B-Chemical
AMP I-Chemical
(cAMP) B-Chemical
accumulation O
by O
the O
human B-Species
immunodeficiency I-Species
virus I-Species
type I-Species
1 I-Species
(HIV B-Species
1) I-Species
protein O
Tat B-Gene
in O
microglia O
and O
astrocyte O
cultures O
obtained O
from O
neonatal O
rat B-Species
brain. O
Pretreatment O
of O
microglia O
with O
recombinant O
Tat B-Gene
resulted O
in O
a O
dose- O
and O
time-dependent O
decrease O
of O
cAMP B-Chemical
accumulation O
induced O
by O
subsequent O
exposure O
to O
isoproterenol B-Chemical
(1 O
microM). O
The O
inhibitory O
action O
of O
100 O
ng O
mL O
Tat B-Gene
approached O
50% O
after O
4 O
h O
of O
preincubation O
and O
reached O
a O
maximum O
of O
70% O
after O
24 O
h. O
The O
Tat-induced O
time- O
and O
dose-dependent O
decrease O
of O
cAMP B-Chemical
accumulation O
was O
observed O
also O
when O
microglial O
cultures O
were O
stimulated O
with O
the O
adenylyl B-Gene
cyclase I-Gene
activator O
forskolin B-Chemical
(100 O
microM). O
In O
both O
cases, O
Tat B-Gene
inhibitory O
action O
was O
70% O
reverted O
by O
a O
specific O
monoclonal O
anti-Tat O
antibody, O
but O
was O
not O
prevented O
either O
by O
the O
phosphodiesterase O
inhibitor O
3-isobutyl-1-methyl-xantine B-Chemical
(100 O
microM) O
or O
by O
a O
16-h O
pretreatment O
of O
microglial O
cultures O
with O
the O
Gi O
protein O
inhibitor O
pertussis O
toxin O
(10 O
ng O
mL). O
All O
these O
results O
suggested O
that O
the O
viral O
protein O
acts O
at O
a O
step O
of O
the O
cAMP B-Chemical
transduction O
pathway O
other O
than O
receptors, O
G O
proteins O
and O
phosphodiesterases. O
The O
target O
of O
Tat B-Gene
appeared O
to O
be O
adenylyl B-Gene
cyclase, I-Gene
whose O
activity O
was O
markedly O
reduced O
(up O
to O
60%) O
in O
membranes O
prepared O
from O
Tat-treated O
microglial O
cells, O
both O
in O
basal O
conditions O
and O
after O
stimulation O
with O
isoproterenol B-Chemical
and O
forskolin. B-Chemical
The O
inability O
of O
the O
competitive O
inhibitor O
of O
nitric B-Chemical
oxide I-Chemical
synthase O
N(G)-monometyl- B-Chemical
L-arginine I-Chemical
(20 O
and O
200 O
microM) O
to O
revert O
Tat B-Gene
action O
on O
forskolin-induced O
cAMP B-Chemical
accumulation, O
and O
of O
two O
potent O
nitric B-Chemical
oxide I-Chemical
donors, O
PAPA O
and O
DETA B-Chemical
(0.1-2 O
m O
M), O
to O
alter O
forskolin-induced O
cAMP B-Chemical
accumulation, O
excluded O
an O
involvement O
of O
nitric B-Chemical
oxide I-Chemical
in O
Tat-induced O
adenylyl B-Gene
cyclase I-Gene
inhibition. O
On O
the O
contrary, O
two O
inhibitors O
of O
nuclear O
factor O
kappaB O
activation, O
N-tosyl-( B-Chemical
L)-phenylalanine I-Chemical
chloromethyl I-Chemical
ketone I-Chemical
(10 O
microM) O
and O
SN50 B-Chemical
(25 O
microM), O
markedly O
prevented O
the O
reduction O
of O
forskolin-evoked O
cAMP B-Chemical
accumulation O
by O
Tat, B-Gene
suggesting O
a O
possible O
role O
for O
this O
nuclear O
transcriptional O
factor O
in O
the O
regulation O
of O
adenylyl B-Gene
cyclase I-Gene
by O
Tat B-Gene
in O
microglia. O
This O
assumption O
was O
strengthened O
by O
the O
ability O
of O
lipopolysaccharide B-Chemical
(100 O
ng O
mL, O
4 O
h) O
to O
mimic O
the O
inhibitory O
effect O
of O
the O
viral O
protein. O
Conversely, O
astrocyte O
cAMP B-Chemical
accumulation O
was O
unaffected O
by O
the O
viral O
protein, O
as O
tested O
at O
various O
concentrations O
and O
time O
points. O
Finally, O
Tat B-Gene
inhibition O
of O
microglial O
adenylyl B-Gene
cyclase I-Gene
was O
not O
due O
to O
non-specific O
cytotoxicity. B-Disease
As O
cAMP B-Chemical
has O
been O
reported O
to O
exert O
a O
neuroprotective O
role O
in O
several O
in O
vivo O
and O
in O
vitro O
models O
of O
brain O
pathologies, O
and O
microglia O
is O
believed O
to O
mediate O
Tat-induced O
neurotoxicity, B-Disease
these O
results O
suggest O
that O
the O
ability O
of O
Tat B-Gene
to O
inhibit O
cAMP B-Chemical
synthesis O
in O
microglia O
may O
contribute O
to O
neuronal B-Disease
degeneration I-Disease
and O
cell B-Disease
death I-Disease
associated O
with O
HIV B-Disease
infection. I-Disease